Diagnostic challenge: Exposed bone in the palate

Journal of the American Dental Association

Volumn 138, Issue 10, 2007, Pages 1341-1343

  Siegel, Michael A ^a   Migliorati, Cesar A ^a   Velez, Ines ^a   Forrest, Mark ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CHLORHEXIDINE; CLINDAMYCIN; METRONIDAZOLE; TOPICAL ANTIINFECTIVE AGENT;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; FEMALE; HARD PALATE; HUMAN; JAW DISEASE; MOUTH ULCER; PATHOLOGY;

AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; BONE DENSITY CONSERVATION AGENTS; CHLORHEXIDINE; CLINDAMYCIN; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; FEMALE; HUMANS; MAXILLARY DISEASES; METRONIDAZOLE; ORAL ULCER; OSTEONECROSIS; PALATE, HARD;

EID: 35548957249     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0049     Document Type: Article

References (8)

1. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21(22):4253-4.
2. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):527-34.
3. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63(11):1567-75.
4. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65(3):369-76. Available at: "www.aaoms.org/docs/position_papers/osteonecrosis.pdf". Accessed Aug. 29, 2007.
5. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. JADA 2006;137(8):1144-50.
6. Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 2006;7(6):508-14.
7. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. JADA 2005;136(12):1658-68.
8. Woo SB, Hellstein JW, Kalmar JR. Narrative (corrected) review: bisphosphonates and osteonecrosis of the jaws (published correction appears in Ann Intern Med 2006;145[3]:235). Ann Intern Med 2006;144(10):753-61.